Trials / Sponsors / Beijing Shenogen Biomedical Co., Ltd
Beijing Shenogen Biomedical Co., Ltd
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carci Hepatocellular Carcinoma | Phase 3 | 2022-12-12 |
| Terminated | The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects Hepatocellular Carcinoma (HCC) | Phase 3 | 2017-09-20 |
| Unknown | The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects Advanced HBV-Related Hepatocellular Carcinoma (HCC) | Phase 3 | 2017-09-08 |
| Completed | The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma Hepatocellular Carcinoma (HCC) | Phase 2 | 2013-10-01 |